Cogent Biosciences
Cogent Biosciences is a publicly traded biotechnology company focused on developing precision therapies for genetically defined diseases. The company’s pipeline includes bezuclastinib, a selective tyrosine kinase inhibitor targeting KIT D816V mutation responsible for systemic mastocytosis and other mutations in KIT exon 17, with top-line results expected in 2025. Cogent also has ongoing studies of FGFR2 inhibitors and a portfolio targeting mutations in ErbB2, PI3Kα, and KRAS. This role involves leading marketing operations to support the launch of bezuclastinib, ensuring compliant, efficient, and impactful promotional activities in a highly regulated therapeutic landscape.
Our culture emphasizes collaboration and innovation, with offices designed to foster teamwork. We value diversity and are committed to equal opportunity employment, focusing on qualifications, merit, and business need.
Key skills identified from this job posting
Sign upto access all insights for this job
Website
cogentbio.com
Company Size
101-250 employees
Location
Waltham, MA
Industry
Research and Development in the Physical, Engineering, and Life Sciences
Other opportunities you might be interested in
Dassault Systemes
American Express
Vineyard vines
Uber
Presidio
Creative Circle